These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20799731)

  • 41. Structures of autoinhibited and polymerized forms of CARD9 reveal mechanisms of CARD9 and CARD11 activation.
    Holliday MJ; Witt A; Rodríguez Gama A; Walters BT; Arthur CP; Halfmann R; Rohou A; Dueber EC; Fairbrother WJ
    Nat Commun; 2019 Jul; 10(1):3070. PubMed ID: 31296852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1.
    Wang D; Matsumoto R; You Y; Che T; Lin XY; Gaffen SL; Lin X
    Mol Cell Biol; 2004 Jan; 24(1):164-71. PubMed ID: 14673152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel CARD11 Mutations in Human Cutaneous Squamous Cell Carcinoma Lead to Aberrant NF-κB Regulation.
    Watt SA; Purdie KJ; den Breems NY; Dimon M; Arron ST; McHugh AT; Xue DJ; Dayal JH; Proby CM; Harwood CA; Leigh IM; South AP
    Am J Pathol; 2015 Sep; 185(9):2354-63. PubMed ID: 26212909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T-cell receptor-induced NF-kappaB activation is negatively regulated by E3 ubiquitin ligase Cbl-b.
    Qiao G; Li Z; Molinero L; Alegre ML; Ying H; Sun Z; Penninger JM; Zhang J
    Mol Cell Biol; 2008 Apr; 28(7):2470-80. PubMed ID: 18227156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methods to Study CARD11-BCL10-MALT1 Dependent Canonical NF-κB Activation in Jurkat T Cells.
    Gewies A; Graß C; Krappmann D
    Methods Mol Biol; 2021; 2366():125-143. PubMed ID: 34236636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Congenital B cell lymphocytosis explained by novel germline CARD11 mutations.
    Snow AL; Xiao W; Stinson JR; Lu W; Chaigne-Delalande B; Zheng L; Pittaluga S; Matthews HF; Schmitz R; Jhavar S; Kuchen S; Kardava L; Wang W; Lamborn IT; Jing H; Raffeld M; Moir S; Fleisher TA; Staudt LM; Su HC; Lenardo MJ
    J Exp Med; 2012 Nov; 209(12):2247-61. PubMed ID: 23129749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma.
    Yang Y; Kelly P; Shaffer AL; Schmitz R; Yoo HM; Liu X; Huang DW; Webster D; Young RM; Nakagawa M; Ceribelli M; Wright GW; Yang Y; Zhao H; Yu X; Xu W; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza L; Staudt LM
    Cancer Cell; 2016 Apr; 29(4):494-507. PubMed ID: 27070702
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated IgE from attenuated CARD11 signaling: lessons from atopic mice and humans.
    Pomerantz JL; Milner JD; Snow AL
    Curr Opin Immunol; 2022 Dec; 79():102255. PubMed ID: 36334349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.
    Takeuchi T; Yamaguchi M; Kobayashi K; Miyazaki K; Tawara I; Imai H; Ono R; Nosaka T; Tanaka K; Katayama N
    Cancer; 2017 Apr; 123(7):1166-1173. PubMed ID: 27915469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chimeric and mutant CARD9 constructs enable analyses of conserved and diverged autoinhibition mechanisms in the CARD-CC protein family.
    Staal J; Driege Y; Van Gaever F; Steels J; Beyaert R
    FEBS J; 2024 Mar; 291(6):1220-1245. PubMed ID: 38098267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Germline CARD11 Mutation in a Patient with Severe Congenital B Cell Lymphocytosis.
    Brohl AS; Stinson JR; Su HC; Badgett T; Jennings CD; Sukumar G; Sindiri S; Wang W; Kardava L; Moir S; Dalgard CL; Moscow JA; Khan J; Snow AL
    J Clin Immunol; 2015 Jan; 35(1):32-46. PubMed ID: 25352053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Host CARD11 Inhibits Newcastle Disease Virus Replication by Suppressing Viral Polymerase Activity in Neurons.
    Wang W; Chang X; Yao W; Wei N; Huo N; Wang Y; Wei Q; Liu H; Wang X; Zhang S; Yang Z; Xiao S
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31554683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MALT1 activation by TRAF6 needs neither BCL10 nor CARD11.
    Bardet M; Seeholzer T; Unterreiner A; Woods S; Krappmann D; Bornancin F
    Biochem Biophys Res Commun; 2018 Nov; 506(1):48-52. PubMed ID: 30336982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex.
    Lu HY; Bauman BM; Arjunaraja S; Dorjbal B; Milner JD; Snow AL; Turvey SE
    Front Immunol; 2018; 9():2078. PubMed ID: 30283440
    [TBL] [Abstract][Full Text] [Related]  

  • 55. BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL.
    Xia M; David L; Teater M; Gutierrez J; Wang X; Meydan C; Lytle A; Slack GW; Scott DW; Morin RD; Onder O; Elenitoba-Johnson KSJ; Zamponi N; Cerchietti L; Lu T; Philippar U; Fontan L; Wu H; Melnick AM
    Cancer Discov; 2022 Aug; 12(8):1922-1941. PubMed ID: 35658124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and Characterization of a Germline Mutation in CARD11 From a Chinese Case of B Cell Expansion With NF-κB and T Cell Anergy.
    Zhao P; Meng Q; Huang Y; Zhang L; Luo S; Zhang X; Tan L; Zhou A; Xiong H; He X
    Front Immunol; 2021; 12():676386. PubMed ID: 34557185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase.
    Steinhardt JJ; Peroutka RJ; Mazan-Mamczarz K; Chen Q; Houng S; Robles C; Barth RN; DuBose J; Bruns B; Tesoriero R; Stein D; Fang R; Hanna N; Pasley J; Rodriguez C; Kligman MD; Bradley M; Rabin J; Shackelford S; Dai B; Landon AL; Scalea T; Livak F; Gartenhaus RB
    Blood; 2014 Dec; 124(25):3758-67. PubMed ID: 25320244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway.
    Thompson RC; Herscovitch M; Zhao I; Ford TJ; Gilmore TD
    J Biol Chem; 2011 Jan; 286(3):1675-82. PubMed ID: 20947507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A
    De Bruyne M; Hoste L; Bogaert DJ; Van den Bossche L; Tavernier SJ; Parthoens E; Migaud M; Konopnicki D; Yombi JC; Lambrecht BN; van Daele S; Alves de Medeiros AK; Brochez L; Beyaert R; De Baere E; Puel A; Casanova JL; Goffard JC; Savvides SN; Haerynck F; Staal J; Dullaers M
    Front Immunol; 2018; 9():2366. PubMed ID: 30429846
    [No Abstract]   [Full Text] [Related]  

  • 60. Cell type-specific regulation of ITAM-mediated NF-kappaB activation by the adaptors, CARMA1 and CARD9.
    Hara H; Ishihara C; Takeuchi A; Xue L; Morris SW; Penninger JM; Yoshida H; Saito T
    J Immunol; 2008 Jul; 181(2):918-30. PubMed ID: 18606643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.